Schedule 13G ownership disclosure
NEWAMSTERDAM PHARMA COMPANY
Security class unavailable · CUSIP: N62509109
Event date: 2023-06-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-086394
- Form type
- SC 13G
- Filer
- NewAmsterdam Pharma Co N.V.
- CIK
- CIK 1936258
- Filed
- Aug 01, 2023
- Reporting period
- Jun 08, 2023
- Description
- Schedule 13G beneficial ownership